Phocas Financial Corp.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1356783 ALAMEDA, CA

Position in BCRX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$3,405,410

+$1,543,870 QoQ

Shares Held

340,541

+74.2% QoQ

Ownership

0.133%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#78

of 316 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Jun 30, 2026

Phocas Financial Corp. holds $23,724,903 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	819,476	$14,185,129
2	BCRX	Biocryst Pharmaceuticals Inc This page	340,541	$3,405,410
3	ELAN	Elanco Animal Health Inc	135,392	$3,331,997
4	SUPN	Supernus Pharmaceuticals, Inc.	60,253	$2,802,367

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,405,410	340,541	+74.2%	Shares	Sole	2026-07-31
2026-03-31	$1,861,540	195,540	-22.0%	Shares	Sole	2026-05-01
2025-12-31	$1,956,216	250,797	—	Shares	Sole	2026-01-26
No filing history on record for this holder in this stock.